comparemela.com

Latest Breaking News On - Biomarker driven therapy - Page 1 : comparemela.com

Advancement in Treating Uncommon EGFR Mutations: Key Takeaways

Discover the latest insights on treating uncommon EGFR mutations, emphasizing the importance of NGS, personalized therapy, and ongoing advancements in TKIs and ADCs.

Precision medicineBiomarker testingTreating uncommonNon small cell lung cancerUncommon egfr mutationsLung cancerLung cancer treatmentPersonalized medicineMutation agnostic agentsBiomarker driven therapyEgfr mutation therapyTreatment options

Investigational Avenues in Uncommon EGFR Mutations: NSCLC Treatment Insight

Experts share treatment experiences with osimertinib and afatinib, the potential role of immunotherapy, and ongoing investigations with ADCs and emerging TKIs for patients with uncommon EGFR mutations.

Precision medicineBiomarker testingNon small cell lung cancerUncommon egfr mutationsNccn guidelinesTreatment sequencingExon 20 insertionsBiomarker driven therapyEgfr mutations

NCCN Announces Research Funding for Biomarker-Directed Therapy in Metastatic Colorectal Cancer, in Collaboration with Fight CRC and Pfizer

/PRNewswire/ The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) today announced new grants awarded to improve quality.

Staceya cohenAnjee davisAmit mahipalMelissa lumishVanessa wookeyFaisal mehmudCase comprehensive cancer centerNational comprehensive cancer networkOncology research programFred hutchinson cancer centerScientific review committeeFox chase cancer centerWide initiative to increase access biomarkerNational comprehensive cancer network oncology research programPfizer incUniversity hospitals seidman cancer center

vimarsana © 2020. All Rights Reserved.